UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.915
AS - Asia 17.503
EU - Europa 6.456
SA - Sud America 1.105
OC - Oceania 203
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 16
Totale 43.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.662
HK - Hong Kong 12.091
SG - Singapore 2.062
CN - Cina 1.663
IT - Italia 1.417
UA - Ucraina 1.414
BR - Brasile 1.000
RU - Federazione Russa 910
DE - Germania 774
IE - Irlanda 632
VN - Vietnam 560
KR - Corea 412
TR - Turchia 391
SE - Svezia 337
FI - Finlandia 313
GB - Regno Unito 210
CA - Canada 172
EE - Estonia 146
IN - India 113
NZ - Nuova Zelanda 102
AU - Australia 98
NL - Olanda 54
AT - Austria 52
FR - Francia 49
MX - Messico 46
AR - Argentina 35
BD - Bangladesh 35
PL - Polonia 33
CZ - Repubblica Ceca 28
IQ - Iraq 28
JP - Giappone 27
ES - Italia 24
ZA - Sudafrica 21
UZ - Uzbekistan 19
EU - Europa 16
EC - Ecuador 15
PK - Pakistan 15
MA - Marocco 14
IL - Israele 13
CO - Colombia 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
ID - Indonesia 10
CL - Cile 9
EG - Egitto 9
BE - Belgio 8
KE - Kenya 8
SA - Arabia Saudita 8
JM - Giamaica 7
NP - Nepal 7
PY - Paraguay 7
CH - Svizzera 6
LT - Lituania 6
PE - Perù 6
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GR - Grecia 5
IR - Iran 4
JO - Giordania 4
LU - Lussemburgo 4
PH - Filippine 4
RO - Romania 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
ET - Etiopia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
ME - Montenegro 2
MK - Macedonia 2
NI - Nicaragua 2
RS - Serbia 2
SV - El Salvador 2
TJ - Tagikistan 2
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
Totale 43.251
Salva come PNG Salva come JPEG
Città #
Hong Kong 12.081
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Singapore 770
Houston 729
Woodbridge 616
Dublin 593
Ashburn 494
Dong Ket 459
Nanjing 399
Andover 368
Izmir 364
Beijing 326
Moscow 312
Boardman 297
Pellezzano 264
Dallas 254
Düsseldorf 216
Mestre 203
Naples 149
Tallinn 146
Norwalk 143
Shenyang 134
Fairfield 131
Los Angeles 124
Salerno 122
Hebei 121
Munich 121
Changsha 110
Nanchang 108
Dearborn 107
São Paulo 87
Jiaxing 85
Rome 62
Redwood City 60
The Dalles 56
Tianjin 56
Nuremberg 54
San Diego 49
New York 48
Pune 47
Auckland 43
Columbus 42
Sydney 42
Brooklyn 41
Ho Chi Minh City 38
San Francisco 37
Council Bluffs 35
Milan 35
Turku 35
West Jordan 35
Santa Clara 33
Washington 33
Belo Horizonte 32
Rio de Janeiro 32
Amsterdam 31
Cambridge 31
Montreal 30
Seattle 30
Jinan 29
Casoria 28
Ottawa 27
Stockholm 27
Boston 24
Warsaw 24
Brasília 22
Hanoi 22
Lappeenranta 22
Atlanta 21
Fort Worth 21
Guangzhou 21
Chicago 20
London 20
Springfield 19
Venezia 18
Chennai 17
Phoenix 17
Shanghai 17
Tashkent 17
Tokyo 17
Vienna 17
Melbourne 16
Brno 15
Curitiba 15
Campinas 14
Lecce 14
Toronto 14
Baghdad 13
Hangzhou 13
Porto Alegre 13
Bologna 12
Brisbane 12
Charlotte 12
Christchurch 12
Hamilton 12
Johannesburg 12
Prineville 12
Totale 33.482
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.147
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 840
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 832
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 793
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 409
Trial of Deferiprone in Parkinson's Disease 359
Neurotransmission in Parkinson's disease: beyond dopamine. 352
Sex Differences in Parkinson’s Disease: From Bench to Bedside 336
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 329
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 300
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 293
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 287
Cognitive impairment in nondemented Parkinson's disease. 279
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 275
Gender differences in microRNA expression in levodopa-naive PD patients 262
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 258
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 251
A simulation tool to plan daily nurse requirements 251
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 236
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 233
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 232
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 231
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 221
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 220
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 215
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 214
A novel phenotype in an Italian family with a rare progranulin mutation 212
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 206
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 196
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 192
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 186
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 180
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 179
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 175
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 174
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 167
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 166
Bilateral facial palsy after COVID-19 vaccination 163
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 163
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 162
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 160
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 155
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 155
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 147
Classifying Different Stages of Parkinson’s Disease Through Random Forests 146
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 144
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 142
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 140
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 138
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 135
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 135
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 133
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 131
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 131
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 130
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 129
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 128
Metabolomics in Parkinson's disease 127
The natural history of multiple system atrophy: A prospective European cohort study 121
Normative data for the Montreal Cognitive Assessment in an Italian population sample 120
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 118
Increased bilirubin levels in de novo Parkinson's disease 118
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 117
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 116
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 115
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 115
Affective theory of mind in patients with Parkinson's disease: comment 114
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 113
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 113
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 113
Trial of Cinpanemab in Early Parkinson's Disease 111
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 111
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 111
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 111
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 109
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study 109
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 109
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 108
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 108
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 106
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 106
Parkin mutations are frequent in patients with isolated early-onset parkinsonism. 106
Sindromi parkinsoniane 106
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 105
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 105
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 104
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 104
The relationship between cerebral vascular disease and parkinsonism: The VADO study. 103
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 103
The alpha-synuclein gene in multiple system atrophy 102
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 102
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 101
D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine. 101
Freezing of gait and executive functions in patients with Parkinson’s disease 101
The accuracy of the arginine growth hormone test in parkinsonism. 100
Gender and non motor fluctuations in Parkinson's disease: A prospective study 100
Diagnosis and management of Parkinson's disease dementia. Oct;62(10):1581-7. Review.PMID: 18822028 99
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 97
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 97
Totale 19.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.621 0 248 270 10 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202613.306 4.870 8.436 0 0 0 0 0 0 0 0 0 0
Totale 44.341